Dr Prashant Mehta, a noted Medical Oncologist and a Bone marrow transplant physician, obtained his DM fellowship in Medical oncology and BMT from the apex institute of the country, AIIMS , New Delhi .
He is also an alumnus of the prestigious Maulana Azad Medical College, New Delhi and was a proud recipient of Meghna Krishna Baweja award for all round excellence at MAMC.
He has received the prestigious Prof GS Bhattacharya award for Best all rounder oncologist in India in the year 2021, from Indian Cooperative Oncology Network (ICON).
His primary areas of focus are Acute Leukemia and Lymphoma in children and adults, Bone marrow transplantation, including haploidentical transplants and reduced toxicity transplantation.
He works as Clinical lead for Lymphoid neoplasms, Haploidentical BMT in adults and children , Lung cancer , gynecological cancer , sarcoma and melanoma.
He has been Prinicipal Investigator for more than 20 clinical trials and is a founder member of ' Science and Cost ' association which works on solutions to improve access to cancer care in India using scientific strategies. He has more than 60 publications in various national and international journals, including book chapters . He is also the Joint editor and web editor for our national oncology journal IJMPO .
Dr Prashant Mehta is credited with the first Bone marrow transplant, first Total Body irradiation based transplant and first MUD transplant in Faridabad region.
His randomized study on dose of Cytarabine during consolidation in Acute Myeloid Leukemia, was selected for oral presentation at ESMO Asia, Singapore. Apart from this he is has a notable presence in various national and international scientific societies.
He is leading the cellular therapy program at Amrita as well as working on making CAR- T cell therapies accessible in India by working in close collaboration with researchers and scientists in India as well as outside. He is skilled in immunotherapy and precision oncology and employs these effectively in suitable scenarios.
Dr Prashant believes that the goal of treatment apart from cure and disease control is happiness and quality of life. He believes in transparency between patient, family and treating Doctor pertaining all aspects of treatment.
The treatment of cancer is complex and associated with different forms of distress for family and patient. Dr Prashant Mehta approaches a patient and disease with the above understanding and hopes to provide comfort and dignity to the patient and the family in difficult situations.
- Lymphoma
- Acute Lymphoblastic Leukaemia
- Multiple Myeloma
- T cell replete
- Haploidentical BMT
- Reduced toxicity conditioning Chemotherapy
- Acute Myeloid Leukemia in children and Adults
- Management of Chronic Myeloid Leukemia in accelerated phase or blast crisis
- Precision oncology, targeted therapy, immunotherapy
- Molecular Oncology
- Lung cancer
- Sarcomas
- Ovarian cancer
- Management of NK/T cell Lymphoma
- Metronomic treatment of Advanced Head and neck cancer
MBBS
Maulana Azad Medical College (MAMC, Delhi) (2006)
MD(Medicine)
Lady Hardinge Medical College, Delhi (2010)
DM(Medical Oncology)
All India Institute of Medical Sciences (AIIMS, Delhi) (2014)
Visiting Physician fellowship in BMT/Cellular Therapy
Fred Hutchinson Cancer research Center, Seattle USA (2016)
- English
- Hindi
- Recipient of the Prestigious ‘Professor GS Bhattacharya Memorial Award’ for Best All rounder Oncologist in India conferred by the Indian Cooperative Oncology Network (ICON) in 2021
- Recipient of the prestigious Meghna Krishna Baweja Memorial award 2001-2002 for all round excellence in 1st Professional MBBS (2001-2002) at Maulana Azad Medical College, Delhi
- Founder Member of Science and Cost Cancer Consortium which is a group of oncologists aiming to improve access to cancer care by utilising scientific principles and drug pharmacokinetics
Dr Prashant Mehta, a noted Medical Oncologist and a Bone marrow transplant physician, obtained his DM fellowship in Medical oncology and BMT from the apex institute of the country, AIIMS , New Delhi .
He is also an alumnus of the prestigious Maulana Azad Medical College, New Delhi and was a proud recipient of Meghna Krishna Baweja award for all round excellence at MAMC.
He has received the prestigious Prof GS Bhattacharya award for Best all rounder oncologist in India in the year 2021, from Indian Cooperative Oncology Network (ICON).
His primary areas of focus are Acute Leukemia and Lymphoma in children and adults, Bone marrow transplantation, including haploidentical transplants and reduced toxicity transplantation.
He works as Clinical lead for Lymphoid neoplasms, Haploidentical BMT in adults and children , Lung cancer , gynecological cancer , sarcoma and melanoma.
He has been Prinicipal Investigator for more than 20 clinical trials and is a founder member of ' Science and Cost ' association which works on solutions to improve access to cancer care in India using scientific strategies. He has more than 60 publications in various national and international journals, including book chapters . He is also the Joint editor and web editor for our national oncology journal IJMPO .
Dr Prashant Mehta is credited with the first Bone marrow transplant, first Total Body irradiation based transplant and first MUD transplant in Faridabad region.
His randomized study on dose of Cytarabine during consolidation in Acute Myeloid Leukemia, was selected for oral presentation at ESMO Asia, Singapore. Apart from this he is has a notable presence in various national and international scientific societies.
He is leading the cellular therapy program at Amrita as well as working on making CAR- T cell therapies accessible in India by working in close collaboration with researchers and scientists in India as well as outside. He is skilled in immunotherapy and precision oncology and employs these effectively in suitable scenarios.
Dr Prashant believes that the goal of treatment apart from cure and disease control is happiness and quality of life. He believes in transparency between patient, family and treating Doctor pertaining all aspects of treatment.
The treatment of cancer is complex and associated with different forms of distress for family and patient. Dr Prashant Mehta approaches a patient and disease with the above understanding and hopes to provide comfort and dignity to the patient and the family in difficult situations.
- Lymphoma
- Acute Lymphoblastic Leukaemia
- Multiple Myeloma
- T cell replete
- Haploidentical BMT
- Reduced toxicity conditioning Chemotherapy
- Acute Myeloid Leukemia in children and Adults
- Management of Chronic Myeloid Leukemia in accelerated phase or blast crisis
- Precision oncology, targeted therapy, immunotherapy
- Molecular Oncology
- Lung cancer
- Sarcomas
- Ovarian cancer
- Management of NK/T cell Lymphoma
- Metronomic treatment of Advanced Head and neck cancer
MBBS
Maulana Azad Medical College (MAMC, Delhi) (2006)
MD(Medicine)
Lady Hardinge Medical College, Delhi (2010)
DM(Medical Oncology)
All India Institute of Medical Sciences (AIIMS, Delhi) (2014)
Visiting Physician fellowship in BMT/Cellular Therapy
Fred Hutchinson Cancer research Center, Seattle USA (2016)
- English
- Hindi
- Recipient of the Prestigious ‘Professor GS Bhattacharya Memorial Award’ for Best All rounder Oncologist in India conferred by the Indian Cooperative Oncology Network (ICON) in 2021
- Recipient of the prestigious Meghna Krishna Baweja Memorial award 2001-2002 for all round excellence in 1st Professional MBBS (2001-2002) at Maulana Azad Medical College, Delhi
- Founder Member of Science and Cost Cancer Consortium which is a group of oncologists aiming to improve access to cancer care by utilising scientific principles and drug pharmacokinetics
Other Doctors
